Canada markets closed

Canntab Therapeutics Limited (PILL.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.6900-0.0100 (-1.43%)
At close: 03:44PM EST
Full screen
Previous Close0.7000
Open0.6800
Bid0.6800 x 0
Ask0.7000 x 0
Day's Range0.6600 - 0.6900
52 Week Range0.5700 - 1.0900
Volume18,900
Avg. Volume27,327
Market Cap25.752M
Beta (5Y Monthly)1.21
PE Ratio (TTM)N/A
EPS (TTM)-0.1160
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateMar. 08, 2016
1y Target EstN/A
  • CNW Group

    CANNTAB OFFICIALLY LAUNCHES ITS ONLINE E-COMMERCE PLATFORM

    Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the "Company" or "Canntab"), a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to announce the official launch of its online e-commerce platform and web site at www.Canntab.ca.

  • GlobeNewswire

    Levitee Labs Partners with Canntab Therapeutics to Provide Alternatives to Opioids

    The agreement is anticipated to contribute to correcting the opioid crisis in Canada and serve as a foundation for both companies to potentially expand into new verticals in the futureLevitee Labs and Canntab Therapeutics have executed a services agreement resulting in Levitee Labs informing patients about the Canntab portfolio of therapeuticsLevitee Labs will offer the entire Canntab product lineup throughout all its clinics and pharmacies in Western Canada VANCOUVER, British Columbia, Jan. 10,

  • CNW Group

    CANNTAB DELIVERS 1st SHIPMENT TO THE ONTARIO CANNABIS STORE AND 2nd SHIPMENT TO AUSTRALIA

    Canntab Therapeutics Limited (CSE:PILL.CN) (OTCQB:CTABF) (FRA:TBF1.F) (the "Company" or "Canntab"), a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to provide an update on its recent product deliveries for Ontario and Australia.